Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Hangzhou Chuhuan Science & Technology Co. Ltd. A stock ¥5.38, price ¥15.28, that is 64.8% below the price, quality 49 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
52‑month range ¥8.56 – ¥25.40 · fair‑value band ¥4.20 – ¥5.48 · the ¥15.28 price screens above the ¥5.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Hangzhou Chuhuan Science & Technology Co. Ltd. A in your weekly email
Every Wednesday you see whether Hangzhou Chuhuan Science & Technology Co. Ltd. A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Hangzhou Chuhuan Science & Technology Company Limited engages in research and development, design, production, and sales of waste gas and odor treatment equipment, water treatment equipment, equipment maintenance, and operation and maintenance services.
Show moreShow less
It offers biological deodorization equipment, Ion deodorization equipment, activated carbon adsorption and desorption equipment, scrubber, regenerative thermal oxidizer, air ducts and fittings, and cover plates.
Hangzhou Chuhuan Science & Technology Company was founded in 2005 and is based in Hangzhou, China.
Stock analysis
Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336) currently trades at ¥15.28, while our model-based Fair Value estimate is ¥5.38, 65% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ¥8.62 per share, and 1 of the 14 models we run sit above the ¥15.28 price.
Bear case: the Dividend Discount group reads lowest at ¥1.31, and 13 of the 14 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ¥4.20 (bear) to ¥5.48 (bull), the price of ¥15.28 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Industrials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Hangzhou Chuhuan Science & Technology Co. Ltd. A reported revenue of 446M CNY in FY2025 versus 587M CNY in FY2021, a compound −6.6%/yr. Reported net income was 38.5M CNY in FY2025, compounding −17.8%/yr from FY2021.
Key figures
Market cap 1.6B CNY (≈ $235M) Micro · P/E ratio 35.5 · P/S ratio 3.29 · EPS (TTM) ¥0.4300 · Dividend yield 0.6% · Net margin 8.7% · Return on equity 5.2% · Return on assets (EBIT) 5.9% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (low confidence).
What moves the price
The share trades about 33% below its 52-week high and 32% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at 3% fair-value upside, at −65%, 001336 screens richer than that median.
Fair Value models
Bear¥4.20Fair Value ¥5.38Bull¥5.48
Price ¥15.28 · Downside -64.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.2898 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.30/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+11.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.1%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.8%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−17.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year−18.2%
Dividend (yield on the price)0.6%
Profit margin 2019 to 2024 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 8%
Compare Hangzhou Chuhuan Science & Technology Co. Ltd. A with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pollution & Treatment Controls · 85 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Hangzhou Chuhuan Science & Technology Co. Ltd. A Fair Value". https://www.fairvalue-calculator.com/stock/001336
Frequently asked questions
Is Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of ¥5.38 versus a price of ¥15.28, about 65% lower (overvalued).
What is the fair value of 001336?
Our model-based fair value for Hangzhou Chuhuan Science & Technology Co. Ltd. A is ¥5.38 (as of Nov 8, 2026), built from audited fundamentals. The current price: ¥15.28.
What is the quality score of 001336?
Hangzhou Chuhuan Science & Technology Co. Ltd. A has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
Our model-based price target is the fair value of ¥5.38 (as of Nov 8, 2026) from 14 valuation models. Cautious scenario ¥4.20, optimistic scenario ¥5.48. It is a calculation from audited fundamentals, not an analyst target.
What is the Hangzhou Chuhuan Science & Technology Co. Ltd. A stock forecast for 2026?
Our models put fair value at ¥5.38, about 65% lower versus a price of ¥15.28 (overvalued). Cautious scenario ¥4.20, optimistic scenario ¥5.48. The calculation is refreshed regularly with new filings.
What is the revenue of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
Hangzhou Chuhuan Science & Technology Co. Ltd. A reported trailing-twelve-month revenue of about 485M CNY (latest available figure, as of Nov 8, 2026).
Does Hangzhou Chuhuan Science & Technology Co. Ltd. A pay a dividend?
Hangzhou Chuhuan Science & Technology Co. Ltd. A currently shows a dividend yield of 0.60% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336) and when is the ex-dividend date?
Hangzhou Chuhuan Science & Technology Co. Ltd. A pays a dividend of ¥0.092 per share a year, a dividend yield of 0.6%. The last ex-dividend date was Jul 28, 2026. The payout ratio is 21.4% of earnings. Our assessment: Token dividend. At a yield of 0.6% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.6% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Hangzhou Chuhuan Science & Technology Co. Ltd. A it is ¥5.38 per share (as of Nov 8, 2026), against a price of ¥15.28. It is the blended result of 14 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Hangzhou Chuhuan Science & Technology Co. Ltd. A stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 001336 trades above its calculated fair value: price ¥15.28, fair value ¥5.38, a gap of about −65% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 001336?
No. The price is what the market pays today (¥15.28); the fair value is what the company's own numbers justify (¥5.38). For Hangzhou Chuhuan Science & Technology Co. Ltd. A the two are ¥9.90 per share apart. That gap is exactly why we show both numbers side by side.
How much is Hangzhou Chuhuan Science & Technology Co. Ltd. A worth?
The market values Hangzhou Chuhuan Science & Technology Co. Ltd. A at about 1.6B CNY (market capitalisation, as of Nov 8, 2026). Per share that is ¥15.28; our models calculate a fair value of ¥5.38 per share.
What do the bullish and bearish scenarios say about 001336?
Our models span a range for Hangzhou Chuhuan Science & Technology Co. Ltd. A: cautious scenario ¥4.20, base ¥5.38, optimistic ¥5.48 per share (as of Nov 8, 2026, price ¥15.28). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 001336?
Hangzhou Chuhuan Science & Technology Co. Ltd. A trades at a price-to-earnings ratio of 35.5 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥5.38 is built from several models across several years. Other multiples: P/B 2.0, P/S 3.3, EV/EBITDA 34.6.
How solid is the balance sheet of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
Balance-sheet figures for Hangzhou Chuhuan Science & Technology Co. Ltd. A (as of Nov 8, 2026): return on equity 5.2%, debt of 0.11 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is 001336 from its 52-week high?
Hangzhou Chuhuan Science & Technology Co. Ltd. A trades at ¥15.28, about 33% below its 52-week high of ¥22.72 and 32% above the low of ¥11.56 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of ¥5.38 is for.
Which stocks are comparable to Hangzhou Chuhuan Science & Technology Co. Ltd. A?
From the same area (Industrials) we also value Veralto Corporation, Zurn Elkay Water Solutions Corporation, Fujian Longking Co, Munters Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Hangzhou Chuhuan Science & Technology Co. Ltd. A stock attractive at the current price?
The data as of Nov 8, 2026: price ¥15.28, calculated fair value ¥5.38 (−65%), Quality Score 49/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 001336 calculated?
We run Hangzhou Chuhuan Science & Technology Co. Ltd. A through 14 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥5.38 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Hangzhou Chuhuan Science & Technology Co. Ltd. A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
The closing price on Nov 9, 2026 was ¥15.28. Our model-based fair value is ¥5.38, about 65% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Hangzhou Chuhuan Science & Technology Co. Ltd. A right now?
The price sits above even our optimistic bull case (¥5.48). The favourable scenario is already priced in. Weak quality (49/100) and above fair value at the same time, the margin of safety is missing on both counts.
Key figures of Hangzhou Chuhuan Science & Technology Co. Ltd. A
How large is the market capitalisation of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
The market capitalisation of Hangzhou Chuhuan Science & Technology Co. Ltd. A is 1.6B CNY (≈ $235M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
The price-to-sales ratio of Hangzhou Chuhuan Science & Technology Co. Ltd. A is 3.29 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
Earnings per share at Hangzhou Chuhuan Science & Technology Co. Ltd. A are ¥0.4300 (price ÷ EPS = P/E 35.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
The dividend yield of Hangzhou Chuhuan Science & Technology Co. Ltd. A is 0.6% (payout 21.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
The net margin of Hangzhou Chuhuan Science & Technology Co. Ltd. A is 8.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
The return on equity (ROE) of Hangzhou Chuhuan Science & Technology Co. Ltd. A is 5.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
On an EBIT basis the return on assets of Hangzhou Chuhuan Science & Technology Co. Ltd. A is 5.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
The operating margin of Hangzhou Chuhuan Science & Technology Co. Ltd. A is 6.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
Revenue at Hangzhou Chuhuan Science & Technology Co. Ltd. A is growing +15.2% versus a year earlier (3y avg −7.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336)?
Earnings per share at Hangzhou Chuhuan Science & Technology Co. Ltd. A are growing −45.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336) generate?
The free cash flow of Hangzhou Chuhuan Science & Technology Co. Ltd. A is −9.7M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336) carry?
The net debt of Hangzhou Chuhuan Science & Technology Co. Ltd. A is 15.3M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Hangzhou Chuhuan Science & Technology Co. Ltd. A in the live analysis
One click puts Hangzhou Chuhuan Science & Technology Co. Ltd. A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 8, 2026